To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Trade, Government Operations.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H06F584330FB04F8CAD9E70DAEC8ECB42: 1. Short title This Act may be cited as the Affordable and Safe Prescription Drug Importation Act of 2024.
- Section H67FA53FE766D40B19D6201B2DD7B7ACC: 2. Findings; sense of Congress Congress finds the following: Prescription drug prices are, on average, 2.78 times more expensive in the United States compared...
- Section H3DCFA7E70F214514870D8E593F8A78B8: 3. Importing affordable and safe drugs Section 804 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 384) is amended to read as follows: 804.Importation...
- Section H75E7BC05DF694789A3A2C859444895BD: 804. Importation of safe and affordable drugs by wholesale distributors, pharmacies, and individuals Not later than 1 year after the date of enactment of the...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Trade, Government Operations
Primary Purpose
This bill, To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
IntroducedMs. Schakowsky (for herself, Mr. Cohen, Mr. Doggett, Mr. Grijalva, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology